IP Verse

T Cell Receptors - EP3440104B2

PatentPatent Analysis

EP3440104

ADAPTIMMUNE
Application Number
EP17716871A
Filing Date
Apr 10, 2017
Status
Patent Maintained As Amended
May 12, 2023
Grant Date
Jun 14, 2023
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP4017984B1
EP3373013B1
EP3060668B2

Bibliography

The patent EP3440104B2 was granted to Adaptimmune on Jun 14, 2023 following the initial filing on Apr 10, 2017 under the application number EP17716871A . The current legal status of the patent is Patent Maintained As Amended.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

DR H ULRICH DORRIESDec 11, 2020ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents